Yiyun Huang

Title: Yiyun Huang: Innovator in Radiolabeled Pharmaceuticals

Introduction

Yiyun Huang is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of radiolabeled pharmaceuticals, holding 2 patents that showcase his innovative work. His inventions focus on methods and compounds that have the potential to advance medical imaging and diagnostics.

Latest Patents

One of Yiyun Huang's latest patents is titled "Radiolabeled pharmaceuticals and methods of making and using same." This invention includes compounds that bind to the synaptic vesicle protein SV2A, which can be utilized as radiotracers for positron emission tomography (PET). The patent also outlines methods for imaging the brain, measuring synaptic density, and diagnosing neurological diseases such as Alzheimer's disease, as well as psychiatric disorders like depression and metabolic disorders such as diabetes through the detection of these compounds using PET.

Another significant patent is "Radioligands for imaging the LPA-1 receptor." This invention pertains to radiolabeled LPA1 receptor antagonists or their pharmaceutically acceptable salts, which are valuable for the quantitative imaging of LPA1 receptors in mammals. These advancements have the potential to enhance the understanding and treatment of various medical conditions.

Career Highlights

Yiyun Huang has worked with prestigious organizations, including Yale University and Bristol-Myers Squibb Company. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yiyun Huang has collaborated with notable colleagues such as Nabeel Nabulsi and Richard E. Carson. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Yiyun Huang's innovative contributions to the field of radiolabeled pharmaceuticals demonstrate his commitment to advancing medical science. His patents not only reflect his expertise but also hold promise for improving diagnostic techniques and treatment options in healthcare.